Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Valerius

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|December 31, 2021
<i>HLA-DRB3/4/5</i> Matching Improves Outcome of Unrelated Hematopoietic Stem Cell TransplantationChrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, et al.
EMBO Molecular Medicine|July 7, 2026
Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapyMariya Chernyavska, K Patricia Hartmann, J H Marco Jansen, et al.
Bone Marrow Transplantation|July 8, 2022
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantationChrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
HLA|July 8, 2022
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective studyChristine Neuchel, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumorsMichel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.
Transplantation and Cellular Therapy|May 7, 2023
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell TransplantationSowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, et al.
Journal for Immunotherapy of Cancer|July 21, 2023
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma modelsMarjolein C Stip, Mitchell Evers, Maaike Nederend, et al.
Nature Biotechnology|December 16, 2025
Antibody-lectin chimeras for glyco-immune checkpoint blockadeJessica C Stark, Melissa A Gray, Itziar Ibarlucea-Benitez, et al.
Nature Communications|February 12, 2026
Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's diseaseAnnika Raschdorf, Larissa Nogueira de Almeida, Philipp Solbach, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|December 31, 2021
<i>HLA-DRB3/4/5</i> Matching Improves Outcome of Unrelated Hematopoietic Stem Cell TransplantationChrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, et al.
EMBO Molecular Medicine|July 7, 2026
Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapyMariya Chernyavska, K Patricia Hartmann, J H Marco Jansen, et al.
Bone Marrow Transplantation|July 8, 2022
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantationChrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
HLA|July 8, 2022
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective studyChristine Neuchel, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumorsMichel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.
Transplantation and Cellular Therapy|May 7, 2023
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell TransplantationSowmya Gowdavally, Chrysanthi Tsamadou, Uwe Platzbecker, et al.
Journal for Immunotherapy of Cancer|July 21, 2023
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma modelsMarjolein C Stip, Mitchell Evers, Maaike Nederend, et al.
Nature Biotechnology|December 16, 2025
Antibody-lectin chimeras for glyco-immune checkpoint blockadeJessica C Stark, Melissa A Gray, Itziar Ibarlucea-Benitez, et al.
Nature Communications|February 12, 2026
Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's diseaseAnnika Raschdorf, Larissa Nogueira de Almeida, Philipp Solbach, et al.
Pageof 11